Actively Recruiting
Lung Cancer Biomarkers and Screening
Led by NYU Langone Health · Updated on 2026-05-08
3606
Participants Needed
1
Research Sites
1565 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.
CONDITIONS
Official Title
Lung Cancer Biomarkers and Screening
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 50 years or older
- Participants at high- or low-risk for lung cancer
- Smoking history of 20 or more pack years, or participants aged 50 or older with less than 20 pack years
- Participants referred for evaluation of suspicious lung nodules diagnosed with lung cancer or nonmalignant nodules
- Not pregnant
- No prior cancer except nonmelanoma skin cancer
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU Cancer Institute at New York University Medical Center
New York, New York, United States, 10016
Actively Recruiting
Research Team
J
James J. Tsay, MD, MSc
CONTACT
R
Rosemary M Schluger
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here